Schobel Alexander Mark 4
4 · Aquestive Therapeutics, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Purchase
Common Stock
2022-06-08$0.96/sh+45,871$44,036→ 882,871 total - Purchase
Warrant (Right to Buy)
2022-06-08$0.13/sh+45,871$5,963→ 45,871 totalExercise: $0.96From: 2022-12-08Exp: 2027-06-08→ Common Stock (45,871 underlying)
Footnotes (1)
- [F1]Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13.